In our CML cohort, the NFE2L2 haplotype GTTC (allele G of SNV rs6721961, T of rs4893819, T of rs35652124, and C of rs6706649) was associated with six times higher risk of disease progression. This evidence concerns the gene NFE2L2 and chronic myelogenous leukemia, BCR-ABL1 positive.